Skip to content

HealthLynked Corp.: 10-Q filed 2025-08-14

What HealthLynked Corp. reported in its quarterly report filed 2025-08-14 (fiscal Q2 2025): 39 published measures, 102 facts as tagged in accession 0001213900-25-076656.

This filing

Form
10-Q (quarterly report)
Filed
2025-08-14
Fiscal period
fiscal Q2 2025
Accession
0001213900-25-076656 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All HealthLynked Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-301,848,450USD
At 2024-12-312,222,989USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-06-306,600,768USD
At 2024-12-315,352,198USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-30-4,752,318USD
At 2025-03-31-4,137,397USD
At 2024-12-31-3,129,209USD
At 2024-06-30-424,579USD
At 2024-03-31221,494USD
At 2023-12-31804,730USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-06-3020,201USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-701,038USD91
2025-01-01 to 2025-06-30-1,751,977USD181
2025-01-01 to 2025-03-31-1,050,939USD90
2024-04-01 to 2024-06-30-1,540,436USD91
2024-01-01 to 2024-06-30-2,928,154USD182
2024-01-01 to 2024-03-31-1,387,718USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-850,089USD181
2024-01-01 to 2024-06-30-1,713,549USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2024-01-01 to 2024-06-302,598USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-06-30794,049USD181
2024-01-01 to 2024-06-301,641,625USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-06-30-2,598USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-06-30-49,916,592USD
At 2024-12-31-48,164,615USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2025-06-30281,947,151shares91
2025-01-01 to 2025-06-30281,947,151shares181
2024-04-01 to 2024-06-30281,788,578shares91
2024-01-01 to 2024-06-30281,136,423shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-04-01 to 2025-06-30281,947,151shares91
2025-01-01 to 2025-06-30281,947,151shares181
2024-04-01 to 2024-06-30281,788,578shares91
2024-01-01 to 2024-06-30281,136,423shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-300USD/shares91
2025-01-01 to 2025-06-30-0.01USD/shares181
2024-04-01 to 2024-06-30-0.01USD/shares91
2024-01-01 to 2024-06-30-0.01USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2025-06-300USD/shares91
2025-01-01 to 2025-06-30-0.01USD/shares181
2024-04-01 to 2024-06-30-0.01USD/shares91
2024-01-01 to 2024-06-30-0.01USD/shares182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-06-30121,314USD
At 2024-12-31176,576USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-06-3012,393USD181
2024-01-01 to 2024-06-30180,168USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-435,385USD91
2025-01-01 to 2025-06-30-1,052,774USD181
2024-04-01 to 2024-06-30-1,079,489USD91
2024-01-01 to 2024-06-30-2,257,527USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-06-301,559,330USD
At 2024-12-311,641,164USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-06-306,125,998USD
At 2024-12-314,689,996USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,027,745USD91
2025-01-01 to 2025-06-302,419,342USD181
2024-04-01 to 2024-06-301,874,567USD91
2024-01-01 to 2024-06-304,056,837USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-06-3027,589USD
At 2024-12-3144,686USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-04-01 to 2025-06-30451,755USD91
2025-01-01 to 2025-06-301,081,170USD181
2024-04-01 to 2024-06-30861,469USD91
2024-01-01 to 2024-06-301,860,912USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-06-30281,947,151shares
At 2024-12-31281,947,151shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-06-3020,201USD
At 2024-12-3176,241USD
At 2024-06-30172,700USD
At 2023-12-31247,222USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-06-3044,962,452USD
At 2024-12-3144,842,829USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-06-30153,813USD
At 2024-12-31361,109USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-06-30153,813USD
At 2024-12-31362,141USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-06-30811,415USD
At 2024-12-31811,415USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-06-30690,101USD
At 2024-12-31634,839USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-06-3078,316USD
At 2024-12-3190,462USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-06-3048,022USD
At 2024-12-3156,719USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2025-06-30155,212USD
At 2024-12-31232,545USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-04-01 to 2025-06-3027,238USD91
2025-01-01 to 2025-06-3055,262USD181
2024-04-01 to 2024-06-3029,531USD91
2024-01-01 to 2024-06-3059,000USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-01-01 to 2025-06-3055,262USD181
2024-01-01 to 2024-06-30171,771USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-265,653USD91
2025-01-01 to 2025-06-30-699,203USD181
2024-04-01 to 2024-06-30-460,947USD91
2024-01-01 to 2024-06-30-670,627USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-06-3013,158USD181
2024-01-01 to 2024-06-3013,158USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2025-01-01 to 2025-06-3010,000USD181
2024-01-01 to 2024-06-30405,000USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-06-3017,698USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-17,097USD181
2024-01-01 to 2024-06-30-36,792USD182

Inspect the source

Entity
HealthLynked Corp. / CIK 0001680139
Captured
2026-09-21T17:24:54.848Z
SEC response SHA-256
1d7da97d254ed8ecb29a71cd1691cea4f80024d23346bfec1c2cf84b10f19e3f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001680139.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))